Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Using rapid atrial pacing to predict the need for pacemaker implantation after TAVI

Official title: Rapid Atrial Pacing After TAVI as a Predictor of Permanent Pacemaker Implantation

Run by National and Kapodistrian University of Athens · NCT06189976 · Data updated 2026-11-12

This study is testing if a quick heart pacing method can help doctors predict which patients will need a permanent pacemaker after getting a new heart valve.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment400 (estimated)
SponsorNational and Kapodistrian University of Athens
Academic / other
Locations2 sites (Brussels and 1 other locations)
StatusRecruiting
StartedMarch 1, 2024
Main results expectedApril 30, 2025
Study endsDecember 31, 2025
Registry record updatedDecember 12, 2024
Trial IDNCT06189976 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older who are undergoing TAVI for severe aortic stenosis and are in sinus rhythm.

Probably not a fit

Patients with ongoing infections, those who already have a permanent pacemaker, or those who develop significant atrioventricular block after TAVI may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of rapid atrial pacing (RAP) as a predictive tool for the necessity of permanent pacemaker implantation (PPI) following transcatheter aortic valve implantation (TAVI). The study aims to assess the atrioventricular conduction system through RAP using a temporary pacemaker lead, which could provide valuable insights into patient management post-TAVI. By evaluating patients undergoing TAVI for severe aortic stenosis, the trial seeks to establish a reliable method for identifying those at risk of requiring PPI. The findings could help refine clinical decision-making and improve patient outcomes.

Why it matters

Potential benefit: If successful, this study could lead to better risk stratification for patients undergoing TAVI, potentially reducing unnecessary pacemaker implantations.

How similar studies have gone: While the approach of using rapid atrial pacing is relatively novel, existing studies have indicated the importance of electrophysiological testing in predicting PPI post-TAVI.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adults ≥18 years old.
2. Patient understands the purpose, the potential risks as well as benefits of the trial and is willing to participate in all parts of the follow-up.
3. Patient has given written consent to participate in the trial.
4. Patients undergoing TAVI as a treatment of severe aortic stenosis (AS).
5. Patient in sinus rhythm.
6. Patients planned for TAVI with utilization of temporary pacemaker electrode placement.

Exclusion Criteria:

1. Ongoing infection, including active endocarditis.
2. Implanted permanent pacemaker and/or implantable cardioverter/defibrillator.
3. Patients developing persistent second or third degree atrioventricular block (AV) after TAVI.
4. Underlying rhythm other than sinus based on the surface ECG leads monitoring after TAVI.
5. Patients with second or third degree AV block identifyied on the screening pre-TAVI ECG.
6. Enrolment in another study that competes or interferes with this study.
7. Subject will not be able to comply with the follow-up requirements according to investigators' opinion.
8. Pregnant or breast-feeding females or females who intend to become pregnant during the time of the study.

Where it's running

  • CHU Saint-Pierre
    Brussels, Belgium
    Recruiting
  • Hippocration Hospital
    Athens, Attica, Greece
    Recruiting

Study contacts

  • Principal investigator: Leonidas Koliastasis — National and Kapodistrian University of Athens
  • Study coordinator: Leonidas Koliastasis, MD, PhD
  • Email: lkoliastasis@gmail.com
  • Phone: +30 6974270752

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.